Would you use OncoType Dx to guide adjuvant therapy recommendations in the context of locally recurrent, node-negative, ER+ breast cancer previously treated with endocrine therapy alone?

Would you utilize Oncotype testing for locally recurrent, node-negative, ER+ breast cancer previously treated with endocrine therapy?

• Yes, would test and would offer chemo for intermediate or high Oncotype score
• Yes, would test and would offer chemo but only for high Oncotype score
• I would not perform Oncotype because I would offer chemo in this setting regardless of risk score
• I would not perform Oncotype because I would offer ET + CDK4/6i in this setting
• I would not perform Oncotype because I would offer endocrine therapy alone in this setting
• I would not perform Oncotype because I would more likely utilize other factors (such as tumor size, grade, Ki-67) to determine use of adjuvant therapies
• Other